Technology

PARIS: “What I miss most is the smell of my son when I kiss him,” says Jean-Michel Maillard. Anosmia — the loss of one’s sense of smell — may be an invisible handicap, but is psychologically difficult to live with and has no real treatment, he says. And it is the price that an increasing number of people are paying …

World Health Organization (WHO) chief scientist last month described AstraZeneca’s COVID-19 vaccine candidate as the world’s leading candidate and most advanced in terms of development. Soumya Swaminathan had said that Moderna’s COVID-19 vaccine candidate was also “not far behind” Astrazeneca’s, among more than 200 candidates, 15 of which have entered clinical trials. Here is what you should know about AstraZeneca’s …

EVER since the coronavirus outbreak forced people to distance, there’s been a lot of talk in financial and tech circles of the accelerating behavioural shift that will push digitisation. But so far, little evidence has surfaced at a broad level to substantiate the claims. To get a better sense of the underlying trends, let’s take a look at the data …

A commercial rocket carrying seven satellites was “lost” after take-off Sunday from a New Zealand launch pad, the owner Rocket Lab said. “We lost the flight late into the mission,” Peter Beck, Rocket Lab’s founder and chief executive, tweeted. “I am incredibly sorry that we failed to deliver our customers’ satellites today. Rest assured we will find the issue, correct …

The World Health Organization (WHO) recently named AstraZeneca’s AZD1222 and Moderna’s mRNA-1273 as two of the leading candidates in the COVID-19 vaccine race. Here we look at what Moderna’s mRNA-1273 has to offer. About mRNA-1273, Moderna’s Vaccine Candidate Against COVID-19 mRNA-1273 is an mRNA vaccine candidate against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was selected by Moderna …

Brazilian health regulator Anvisa on Friday approved clinical trials of a potential coronavirus vaccine developed by China’s Sinovac, according to an official gazette publication. The study – first announced on June 11 – is led by Instituto Butantan, a research center funded by the state of Sao Paulo. The agreement with Sinovac includes not only trials but also the transference …

China’s military last month received the greenlight to use a COVID-19 vaccine candidate, Ad5-nCoV, developed by its research unit and CanSino Biologics. The Ad5-nCoV is one of China’s eight vaccine candidates approved for human trials at home and abroad for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada. China’s Central …

Switzerland announced Thursday that COVID-19 patients beyond those on clinical trials could be given remdesivir, the first drug shown to be relatively effective in treating the new coronavirus. At least two major US studies have shown that the anti-viral drug can reduce the duration of hospital stays for those suffering from the novel coronavirus. “With immediate effect, remdesivir can be …

SEOUL: An augmented reality (AR) mirror at the new Seoul flagship boutique of cosmetics powerhouse Amorepacific makes easy work of seeing if that scarlet shade of lipstick or long-lash mascara suits you – even if you’re wearing a face mask. The mirror takes a photograph of the customer’s face and analyses it, recommending products based on skin texture, and addressing …

Facebook’s WhatsApp messaging service has announced a number of new features for its users. The new features are rolling out over the next few weeks. One of the more notable features is dark mode, which is now available on the web and desktop versions of WhatsApp. The social messaging app had been working on bringing animated stickers for some time …